Letermovir is used alone or together with another medicine (eg, cyclosporine) to prevent cytomegalovirus (CMV) infection and disease in patients who have received an allogeneic hematopoietic stem cell (bone marrow) transplant or in patients who have received kidney transplant who have a high risk for getting CMV disease.<\/p>\n
If LETERMOVIR Tablets\u00a0<\/strong>are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n Note:<\/strong> Medicine Name:<\/strong> Prevymis If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import LETERMOVIR Tablets<\/strong>\u201d based on the information you provide.<\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n","protected":false},"excerpt":{"rendered":"letermovir injection, for intravenous use Initial U.S. Approval: 2017<\/h2>\n
\nGeneric Name:<\/strong> Letermovir
\nDosage Form & Strength:<\/strong> Tablet: 240 mg; 480 mg and Injection: 240 mg\/12 mL (20 mg\/mL) or 480 mg\/24 mL (20 mg\/mL) in a single-dose vial
\nManufactured By:<\/strong> Merck<\/p>\nAccess the best support services globally<\/h4>\n